Treatment steps |
NTS Group |
Control Group |
Significance |
Call for help (yes/no) |
Yes: 51.20% No: 48.80% |
Yes: 35.30% No: 64.70% |
χ2(1) = 1.94, p =
.16 |
Return of spontaneous circulation
(yes/no) |
Yes: 39.50% No: 60.50% |
Yes: 32.40% No: 67.60% |
χ2(1) = 0.42, p =
.52 |
Time until emergency call(s) |
303.00 ± 39.90 |
335.80 ± 41.20 |
U = 120.00, z = -0.43, p = .68 |
Time until first
defibrillation(s) |
184.80 ± 8.60 |
178.40 ± 11.20 |
U = 698.50, z = .72, p = .47 |
Time until return of spontaneous
circulation(s) |
435.00 ± 26.80 |
466.00 ± 21.50 |
t(26) = 0.83, p =
.41 |
Anaphylactic
shock scenario II |
Treatment steps |
NTS Group |
Control Group |
Significance |
Call for help (yes/no) |
Yes: 46.50% No: 53.50% |
Yes: 23.50% No: 76.50 % |
χ2 (1) = 4.33, p =
.04 |
Provided oxygen therapy via
non-rebreathing mask (yes/no) |
Yes: 93.00% No: 7.00% |
Yes: 94.10% No: 5.90% |
χ2 (1) = 0.04, p =
.85 |
Adrenaline administration
(yes/no) |
Yes: 48.80% No: 51.20% |
Yes: 64.70% No: 35.30% |
χ2 (1) = 1.94, p =
.16 |
Antihistamine administration
(yes/no) |
Yes: 69.80% No: 30.20% |
Yes: 67.60% No: 32.40% |
χ2 (1) = 0.04, p =
.84 |
Initiation of blood volume expansion
therapy (yes/no) |
Yes: 55.80% No: 44.10% |
Yes: 67.60% No: 32.40% |
χ2 (1) = 1.12, p =
.29 |
Patient´s condition improved
(yes/no) |
Yes: 39.50% No: 60.50% |
Yes: 38.20% No: 61.80% |
χ2 (1) = 0.01, p =
.91 |
Time until emergency call(s) |
318.40 ± 34.40 |
356.90 ± 49.90 |
t(27) = 0.60, p =
.55 |
Time until oxygen
administration(s) |
152.30 ± 17.20 |
153.50 ± 18.90 |
U = 623.50, z = 0.41, p = .69 |
Time until adrenaline
administration(s) |
322.50 ± 20.80 |
336.60 ± 27.30 |
t(41)= 0.41, p = .69 |
Time until antihistamine
administration(s) |
247.20 ± 18.70 |
189.60 ± 13.90 |
U = 470.50, z = 2.26, p = .02 |
Time until initiation of blood
volume expansion therapy(s) |
219.00 ± 21.00 |
285.00 ± 21.00 |
U = 167.50, z = -2.31, p = .02 |
Time until
patient´s condition improved(s) |
273.10
± 13.70 |
241.80
± 14.30 |
t(28)= -1.56, p = .13 |